Thu, 13 Feb 2025
U.S. investors and large pharmaceutical companies are increasingly doing deals in China as the country's biopharma sector transforms.
>>
Terms of Use | Privacy Policy | Manage Cookies+ | Ad Choices | Accessibility & CC | About | Newsletters | Transcripts
Business News Top © 2024-2025